The plasma level of Hsp90α in patients with different stages of liver cancers was statistically significant (P = 0.005, 0.046, and <0.001 for I vs II, III vs IV, and I + II vs III + IV, respectively). The gene discussed is HSP90AA1; the disease is liver cancer.